MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
1097.32%
Quick Ratio
1097.32%
Cash Ratio
128.21%
Debt to Asset Ratio
8.39%
Unit: Thousand (K) dollars
Assets Breakdown
Marketable debt securities
Marketable debt securities, non-...
Cash and cash equivalents
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
17,076
14,737
49,657
12,551
Marketable debt securities
125,418
121,049
105,897
120,119
Prepaid expenses and other current assets
3,658
4,211
3,950
2,974
Total current assets
146,152
139,997
159,504
135,644
Restricted cash, non-current
745
745
745
745
Marketable debt securities, non-current
19,356
41,641
42,336
957
Property and equipment, gross
-
-
2,227
-
Less accumulated depreciation
-
-
1,468
-
Property and equipment, net
1,318
669
759
828
Operating lease right-of-use asset
2,602
2,891
3,174
3,452
Other assets
5,920
5,980
2,950
3,010
Total assets
176,093
191,923
209,468
144,636
Accounts payable
4,663
4,031
3,468
4,504
Accrued expenses and other current liabilities
7,370
3,627
6,229
4,185
Operating lease liability
1,286
1,264
1,242
1,220
Total current liabilities
13,319
8,922
10,939
9,909
Operating lease liability, non-current
1,463
1,793
2,117
2,436
Total liabilities
14,782
10,715
13,056
12,345
Common stock, 59,083,935 and 53,587,260 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
59
55
54
39
Additional paid-in capital
503,484
501,718
498,687
417,221
Accumulated deficit
-341,869
-320,201
-302,419
-285,112
Accumulated other comprehensive income (loss)
-363
-364
90
143
Total stockholders equity
161,311
181,208
196,412
132,291
Total liabilities and stockholders equity
176,093
191,923
209,468
144,636
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Marketable debt securities
$125,418K
(38.25%↑ Y/Y)
Cash and cash
equivalents
$17,076K
(-45.78%↓ Y/Y)
Prepaid expenses and
other current assets
$3,658K
(27.23%↑ Y/Y)
Total current assets
$146,152K
(16.84%↑ Y/Y)
Marketable debt
securities, non-current
$19,356K
(-17.25%↓ Y/Y)
Other assets
$5,920K
(92.96%↑ Y/Y)
Operating lease
right-of-use asset
$2,602K
(-30.15%↓ Y/Y)
Property and equipment,
net
$1,318K
(44.52%↑ Y/Y)
Restricted cash,
non-current
$745K
(0.00%↑ Y/Y)
Total assets
$176,093K
(12.21%↑ Y/Y)
Total liabilities and
stockholders equity
$176,093K
(12.21%↑ Y/Y)
Total stockholders
equity
$161,311K
(11.69%↑ Y/Y)
Total liabilities
$14,782K
(18.16%↑ Y/Y)
Accumulated deficit
-$341,869K
(-25.75%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$363K
(-571.43%↓ Y/Y)
Additional paid-in capital
$503,484K
(20.98%↑ Y/Y)
Total current
liabilities
$13,319K
(36.45%↑ Y/Y)
Operating lease
liability, non-current
$1,463K
(-46.78%↓ Y/Y)
Common stock,
59,083,935 and 53,587,260...
$59K
(51.28%↑ Y/Y)
Accrued expenses and
other current...
$7,370K
(125.87%↑ Y/Y)
Accounts payable
$4,663K
(-12.00%↓ Y/Y)
Operating lease liability
$1,286K
(7.26%↑ Y/Y)
Buy us a coffee
Protara Therapeutics, Inc. (TARA)
Protara Therapeutics, Inc. (TARA)